Lamotrigine Biogaran (Lamotrigine)

Lamotrigine works by blocking voltage‑gated sodium channels on neuronal membranes, which reduces the release of excitatory neurotransmitters such as glutamate. This stabilises neuronal activity, decreasing seizure frequency and contributing to mood stabilization in bipolar disorder.

The dose of Lamotrigine Biogaran is individualised by the prescriber based on the patient’s condition, age, renal and hepatic function, and concomitant medications. The prescribing physician determines the appropriate starting dose and titration schedule.

The safety of lamotrigine in pregnancy is not fully established, and it is classified as a pregnancy category with unknown risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential benefits and risks with their healthcare provider before using the medication.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lamotrigine is distinguished by its broad spectrum of activity against both focal and generalized seizures and its mood‑stabilising properties, which many other antiepileptics lack. Compared with older agents such as carbamazepine, it has a lower risk of enzyme induction but requires careful titration to avoid skin reactions.

Lamotrigine Biogaran should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date.

Lamotrigine Biogaran is taken orally, usually as a tablet. It should be swallowed whole with water and can be taken with or without food, following the dosing schedule prescribed by the treating physician.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood disorders like agranulocytosis, hepatic failure, and the emergence of suicidal thoughts. Immediate medical attention is required if any of these symptoms appear.

Lamotrigine Biogaran is contraindicated in patients with a known hypersensitivity to lamotrigine or any of its excipients. It should also be avoided in individuals with a history of severe skin reactions to the drug and in patients for whom the risk–benefit profile is unfavorable, as determined by their clinician.